Allergen-Specific Immunotherapy

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2500.0%

Death Rate

Active Ingredients

Allergen-Specific Immunotherapy

Administration Routes

UnknownParenteralOtherSubcutaneous

Species Affected

Dog 14

Cat 2

Most Affected Breeds

Domestic Shorthair 2

Spaniel - Cocker American 2

Poodle - Toy 2

Retriever - Golden 2

Retriever - Labrador 1

Bulldog - American 1

Collie - Border 1

Mixed (Dog) 1

Hound (unspecified) 1

Collie (unspecified) 1

Most Reported Reactions

Death by euthanasia 3

Wheezing 2

Respiratory discomfort 2

Weight loss 2

Vomiting 2

Abnormal ultrasound finding 2

Digestive tract neoplasm NOS 2

Elevated serum alkaline phosphatase (SAP) 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Neutropenia 2

Anaemia NOS 2

Loss of hearing 2

Outcome Breakdown

Recovered/Normal

4 (25.0%)

Ongoing

4 (25.0%)

Outcome Unknown

4 (25.0%)

Euthanized

3 (18.8%)

Died

1 (6.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.